Showing results (231-240 of 301) with videos related to
Sort By:
Pageof 31
Japanese Journal of Clinical Oncology|March 10, 2025
Comparing oncological outcomes and safety between photodynamic diagnosis-assisted and white-light transurethral resection in elderly patients with non-muscle invasive bladder cancerYuto Matsushita, Yoshihiro Tsuchiya, Gaku Ishikawa, et al.Oncotarget|September 10, 2019
Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapySatoshi Tsunetoh, Yoshito Terai, Masaaki Takai, et al.Journal of Radiation Research|May 15, 2023
Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry databaseMasayuki Araya, Hitoshi Ishikawa, Kentaro Nishioka, et al.Contemporary Clinical Trials Communications|February 22, 2021
Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) - A study protocol for an open-label, phase II, multicenter studyYuta Sekino, Hitoshi Ishikawa, Tomokazu Kimura, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumorsTeruo Inamoto, Taketo Yamada, Kei Ohnuma, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient miceHayahito Nomi, Junko Tashiro-Yamaji, Yumiko Yamamoto, et al.Proceedings of the National Academy of Sciences of the United States of America|May 18, 2016
Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expressionKazumasa Komura, Seong Ho Jeong, Kunihiko Hinohara, et al.Signal Transduction and Targeted Therapy|July 17, 2026
A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancerTakuya Tsujino, Shogo Yamazaki, Moritoshi Sakamoto, et al.Japanese Journal of Clinical Oncology|September 4, 2013
Adverse event profile and dose modification of everolimus for advanced renal cell carcinoma in real-world Japanese clinical practiceMasahiro Nozawa, Norio Nonomura, Takeshi Ueda, et al.Hinyokika Kiyo. Acta Urologica Japonica|September 19, 2007
[Ureteral-abdominal aortic fistula during the exchange of ureteral stenting: a case report]Naoki Segawa, Syuji Hamada, Kiyoshi Takahara, et al.Pageof 31